ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

A Agilent Technologies

132,73
0,29 (0,22%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:21:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Agilent Technologies A NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,29 0,22% 132,73 22:21:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
133,06 132,15 133,74 132,73 132,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202422:31PRNCAReitmans (Canada) Limited Reports Fiscal 2024 and Fourth..
16.4.202414:00BWAgilent Receives Scientists' Choice Awards for..
15.4.202414:00BWAgilent Receives European IVDR Class C Certification for..
04.4.202414:00BWAgilent Brings Great Science to Life at Analytica 2024
03.4.202414:00BWAgilent at AACR 2024: Empowering Breakthroughs in Cancer..
02.4.202414:00BWAgilent and UC San Diego Launch Center of Excellence in..
01.4.202414:00BWAgilent Launches New Advanced Dilution System to Increase..
14.3.202413:00BWAgilent Presents 2024 Darlene Solomon Award to University of..
08.3.202419:08EDGAR2Form 144 - Report of proposed sale of securities
08.3.202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202416:04EDGAR2Form 144 - Report of proposed sale of securities
07.3.202421:41EDGAR2Form 144 - Report of proposed sale of securities
05.3.202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202420:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.3.202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202402:05EDGAR2Form 144 - Report of proposed sale of securities
01.3.202420:13EDGAR2Form 144 - Report of proposed sale of securities
29.2.202414:00BWAgilent Presents Solutions Innovation Research Awards to..
27.2.202422:06EDGAR2Form 8-K - Current report
27.2.202422:05BWAgilent Reports First-Quarter Fiscal Year 2024 Financial..
21.2.202422:20BWAgilent Announces Cash Dividend of 23.6 Cents per Share
21.2.202422:15EDGAR2Form 8-K - Current report
21.2.202422:12BWAgilent CEO Mike McMullen to Retire; Agilent CrossLab Group..
13.2.202416:11BWAgilent Ranked Among Top 50 Most Just Companies in America
08.2.202414:00BWAgilent Wins Two Scientists’ Choice Awards for Drug..
07.2.202417:20BWAgilent to Participate in TD Cowen Health Care Conference
02.2.202414:10EDGAR2Form DEF 14A - Other definitive proxy statements
02.2.202414:00EDGAR2Form ARS - Annual Report to Security Holders
30.1.202414:00BWAgilent Announces Collaboration with Incyte to Develop..
25.1.202418:29BWAgilent to Announce First-Quarter Fiscal Year 2024 Financial..
16.1.202414:00BWAgilent Announces New ProteoAnalyzer System
05.1.202422:05EDGAR2Form 8-K - Current report
05.1.202416:29BWAgilent Named to Dow Jones Sustainability Indices for Ninth..
28.12.202319:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202316:46EDGAR2Form 144 - Report of proposed sale of securities
20.12.202315:11EDGAR2Form 8-K - Current report
20.12.202314:58BWAgilent Makes Strategic Updates to Organizational Structure
19.12.202320:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:59EDGAR2Form 144 - Report of proposed sale of securities
18.12.202316:01BWAgilent to Present at the 42nd Annual J.P. Morgan Healthcare..
15.12.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202320:14EDGAR2Form 144 - Report of proposed sale of securities
14.12.202321:17BWAgilent Again Named “Global Lighthouse” by World Economic..
13.12.202317:12EDGAR2Form 144 - Report of proposed sale of securities
08.12.202320:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202317:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202317:41EDGAR2Form 144 - Report of proposed sale of securities
07.12.202314:00BWAgilent Resolve Raman Receives Multiple Recognitions for..
04.12.202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock